{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:13:11Z","timestamp":1784049191791,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1455500"],"award-info":[{"award-number":["22ZR1455500"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1456100"],"award-info":[{"award-number":["23ZR1456100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473508"],"award-info":[{"award-number":["82473508"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10495-026-02383-2","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:23:17Z","timestamp":1782202997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRKL amplification synergizes with mechanical stress-induced signaling to dually activate YAP oncogenic pathways, driving plantar melanoma progression"],"prefix":"10.1007","volume":"31","author":[{"given":"Jiashe","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"2383_CR1","doi-asserted-by":"crossref","unstructured":"Alpaslan T, Ryan J S, Alexander K, et al. (2025) Cutaneous melanoma. Nat Rev Dis Primers 11.","DOI":"10.1038\/s41572-025-00612-7"},{"key":"2383_CR2","doi-asserted-by":"crossref","unstructured":"Patricia P C, Valeria P, Richard M. (2023) The journey from melanocytes to melanoma. Nat Rev Cancer 23.","DOI":"10.1038\/s41568-023-00565-7"},{"key":"2383_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2383_CR4","first-page":"74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"2383_CR5","unstructured":"Francesca F, Christian U B. (2025) Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape. Nat Rev Immunol."},{"key":"2383_CR6","unstructured":"Urvashi Mitbander J, Mohammed K-S, John M K. (2025) Cutaneous melanoma: a review. JAMA."},{"key":"2383_CR7","doi-asserted-by":"crossref","unstructured":"Lili M, Bin L, Caili L, et al. (2023) Camrelizumab plus apatinib and temozolomide as first-line treatment in patients with advanced acral melanoma: the CAP 03 phase 2 nonrandomized clinical trial. JAMA Oncol 9.","DOI":"10.1001\/jamaoncol.2023.1363"},{"key":"2383_CR8","doi-asserted-by":"crossref","unstructured":"Ryan C A, Sarah N, Aofei L, et al. (2023) Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma. J Immunother Cancer 11.","DOI":"10.1136\/jitc-2023-007567"},{"key":"2383_CR9","doi-asserted-by":"crossref","unstructured":"Yian Ann C, Jamie K T, Zeynep E, et al. (2019) Translational pathology, genomics and the development of systemic therapies for acral melanoma. Semin Cancer Biol 61.","DOI":"10.1016\/j.semcancer.2019.10.017"},{"key":"2383_CR10","doi-asserted-by":"crossref","unstructured":"In\u00e9s dlR, Pol S, Christopher R, et al. (2025) High copy number variations correlate with a pro-tumoral microenvironment and worse prognosis in acral lentiginous melanoma. Int J Mol Sci 26.","DOI":"10.3390\/ijms26094097"},{"key":"2383_CR11","doi-asserted-by":"crossref","unstructured":"Anna Luiza Silva Almeida V, Alexei N, Vincent C, et al. (2022) Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure. Nat Commun 13.","DOI":"10.1038\/s41467-022-31488-w"},{"key":"2383_CR12","doi-asserted-by":"crossref","unstructured":"Meng W, Satoshi F, Yi-Shuan S, et al. (2024) The genetic evolution of acral melanoma. Nat Commun 15.","DOI":"10.1038\/s41467-024-50233-z"},{"key":"2383_CR13","doi-asserted-by":"crossref","unstructured":"Farshad F, Kahn R, Chaya L, et al. (2022) Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis. Nat Commun 13.","DOI":"10.1038\/s41467-022-28566-4"},{"key":"2383_CR14","doi-asserted-by":"crossref","unstructured":"Qiong S, Lin L, Jianru C, et al. (2022) Integrative genomic profiling uncovers therapeutic targets of acral melanoma in Asian populations. Clin Cancer Res 28.","DOI":"10.1158\/1078-0432.CCR-21-3344"},{"key":"2383_CR15","doi-asserted-by":"crossref","unstructured":"Iwei Y, Eric J, Ling S, et al. (2019) Targeted genomic profiling of acral melanoma. J Natl Cancer Inst 111.","DOI":"10.1093\/jnci\/djz005"},{"key":"2383_CR16","doi-asserted-by":"crossref","unstructured":"Joshua M W, Miranda V H, Nelly M C, et al. (2022) Anatomic position determines oncogenic specificity in melanoma. Nature 604.","DOI":"10.1038\/s41586-022-04584-6"},{"key":"2383_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12967-022-03856-z","volume":"21","author":"R Huang","year":"2023","unstructured":"Huang R, Shen G, Ren Y et al (2023) Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma. J Transl Med 21:78","journal-title":"J Transl Med"},{"key":"2383_CR18","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ccell.2024.04.012","volume":"42","author":"H Liu","year":"2024","unstructured":"Liu H, Gao J, Feng M et al (2024) Integrative molecular and spatial analysis reveals evolutionary dynamics and tumor-immune interplay of in situ and invasive acral melanoma. Cancer Cell 42:1067-1085.e1011","journal-title":"Cancer Cell"},{"key":"2383_CR19","doi-asserted-by":"crossref","unstructured":"Taeju P. (2021) Crk and CrkL as therapeutic targets for cancer treatment. Cells 10.","DOI":"10.3390\/cells10040739"},{"key":"2383_CR20","doi-asserted-by":"crossref","unstructured":"Pegah F, Taeju P. (2025) The p130Cas-Crk\/CrkL Axis: a therapeutic target for invasive cancers unveiled by collaboration among p130Cas, Crk, and CrkL. Int J Mol Sci 26.","DOI":"10.3390\/ijms26094017"},{"key":"2383_CR21","unstructured":"Kari J K, Yao L, Ciric T, et al. (2020) Treatment-Induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. Cancer Cell 37."},{"key":"2383_CR22","doi-asserted-by":"crossref","unstructured":"Cheng Y, Huijie Y, Peng S, et al. (2022) OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer. Oncogene 41.","DOI":"10.1038\/s41388-022-02507-3"},{"key":"2383_CR23","doi-asserted-by":"crossref","unstructured":"Richard C, Carsten Gram H. (2022) The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin Sci (Lond) 136.","DOI":"10.1042\/CS20201474"},{"key":"2383_CR24","unstructured":"Stefano P, Tito P, Paolo C, Michelangelo C. (2022) YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer 4."},{"key":"2383_CR25","doi-asserted-by":"crossref","unstructured":"Georg H, Sirio D, Stefano P. (2012) Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat Rev Mol Cell Biol 13.","DOI":"10.1038\/nrm3416"},{"key":"2383_CR26","doi-asserted-by":"crossref","unstructured":"Wonyul J, Tackhoon K, Ja Seung K, Sang-Kyum K, Dae-Sik L. (2017) Mechanical cue-induced YAP instructs Skp2-dependent cell cycle exit and oncogenic signaling. EMBO J 36.","DOI":"10.15252\/embj.201696089"},{"key":"2383_CR27","doi-asserted-by":"crossref","unstructured":"Jimyung S, HyunSeok K, Kyoung Il M, et al. (2022) Weight-bearing activity impairs nuclear membrane and genome integrity via YAP activation in plantar melanoma. Nat Commun 13.","DOI":"10.1038\/s41467-022-29925-x"},{"key":"2383_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116840","volume":"235","author":"J Chen","year":"2025","unstructured":"Chen J, Xu M, Wu F et al (2025) CRKL silencing inhibits melanoma growth and enhances its chemotherapy sensitivity through the PI3K\/AKT and NLRP3\/GSDMD pathways. Biochem Pharmacol 235:116840","journal-title":"Biochem Pharmacol"},{"key":"2383_CR29","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41467-022-29925-x","volume":"13","author":"J Seo","year":"2022","unstructured":"Seo J, Kim H, Min KI et al (2022) Weight-bearing activity impairs nuclear membrane and genome integrity via YAP activation in plantar melanoma. Nat Commun 13:2214","journal-title":"Nat Commun"},{"key":"2383_CR30","doi-asserted-by":"crossref","unstructured":"Huijie Y, Jiayao C, Peng S, et al. (2025) Oxytocin receptor regulates the Hippo\/YAP axis to drive hepatocarcinogenesis. Cancer Res 85.","DOI":"10.1158\/0008-5472.CAN-24-3405"},{"key":"2383_CR31","doi-asserted-by":"crossref","unstructured":"Peiyi X, Mincheng Y, Bo Z, et al. (2024) CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma. J Hepatol 81.","DOI":"10.1016\/j.jhep.2024.02.009"},{"key":"2383_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5021\/ad.2021.33.3.228","volume":"33","author":"JH Lee","year":"2021","unstructured":"Lee JH, Choi YD, Hwang JH, Shin MH, Yun SJ (2021) Frequency of trauma, physical stress, and occupation in acral melanoma: analysis of 313 acral melanoma patients in Korea. Ann Dermatol 33:228\u2013236","journal-title":"Ann Dermatol"},{"key":"2383_CR33","doi-asserted-by":"crossref","unstructured":"Collin M C, Mark R P, Aaron R M. (2017) Acral melanoma and mechanical stress on the plantar surface of the foot. N Engl J Med 377.","DOI":"10.1056\/NEJMc1706162"},{"key":"2383_CR34","doi-asserted-by":"crossref","unstructured":"Ho Joo J, Sun-Seog K, Jee-Bum L, Seung-Chul L, Sook Jung Y. (2013) A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress. JAMA Dermatol 149.","DOI":"10.1001\/jamadermatol.2013.5853"},{"key":"2383_CR35","doi-asserted-by":"crossref","unstructured":"Michele M N, Yekaterina A M, Leah C B, et al. (2020) Heterochromatin-driven nuclear softening protects the genome against mechanical stress-induced damage. Cell 181.","DOI":"10.1016\/j.cell.2020.03.052"},{"key":"2383_CR36","doi-asserted-by":"crossref","unstructured":"Celine M D, Rachel M G, Philipp I, et al. (2016) Nuclear envelope rupture and repair during cancer cell migration. Science 352.","DOI":"10.1126\/science.aad7297"},{"key":"2383_CR37","doi-asserted-by":"crossref","unstructured":"M R, M G, H dB, et al. (2016) ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death. Science 352.","DOI":"10.1126\/science.aad7611"},{"key":"2383_CR38","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1038\/s41388-020-1362-9","volume":"39","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yang L, Szeto P et al (2020) The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis. Oncogene 39:5267\u20135281","journal-title":"Oncogene"},{"key":"2383_CR39","doi-asserted-by":"crossref","unstructured":"Min Hwan K, Jongshin K, Hyowon H, et al. (2015) Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP\/TAZ activation. EMBO J 35.","DOI":"10.15252\/embj.201592081"},{"key":"2383_CR40","unstructured":"Luping L, Amit J S, Elton C, et al. (2015) The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat Genet 47."},{"key":"2383_CR41","doi-asserted-by":"crossref","unstructured":"Felicity N, James S W, Peter A J, et al. (2020) Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nat Commun 11.","DOI":"10.1038\/s41467-020-18988-3"},{"key":"2383_CR42","unstructured":"Nicholas K H, James S W, Nicola W, et al. (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545."},{"key":"2383_CR43","doi-asserted-by":"crossref","unstructured":"Youngmin A L, Luke A N, Kemal M A, et al. (2018) Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap. Nat Commun 9.","DOI":"10.1038\/s41467-018-07338-z"},{"key":"2383_CR44","doi-asserted-by":"crossref","unstructured":"Jayanta D, Noor G, Kevin M R. (2023) Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol 24.","DOI":"10.1038\/s41580-023-00585-z"},{"key":"2383_CR45","doi-asserted-by":"crossref","unstructured":"Ryan C R, Kun-Liang G. (2022) The multifaceted role of autophagy in cancer. EMBO J 41.","DOI":"10.15252\/embj.2021110031"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02383-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02383-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02383-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:02:11Z","timestamp":1784048531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02383-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2383"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02383-2","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol involving human tissues received approval (2022-33) from the Ethics Committee of Shanghai Skin Diseases Hospital. All animal experiments were conducted in compliance with the institutional ethical guidelines after obtaining approval (2025\u2009\u2212\u2009141) from the same committee, following both the Experimental Animal Administration Committee of Shanghai standards and Tongji University\u2019s animal research regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"179"}}